Acumen Pharmaceuticals (ABOS) Invested Capital (2023 - 2026)

Acumen Pharmaceuticals (ABOS) has 3 years of Invested Capital data on file, last reported at $14.1 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital changed N/A year-over-year to $14.1 million; the trailing twelve-month figure through Mar 2026 stood at $26.5 million (changed N/A YoY), and the FY2025 full-year result was $8.8 million, changed N/A from the prior year.
• Invested Capital grew to $14.1 million in Q1 2026, from $8.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $14.1 million in Q1 2026 to a low of $756000.0 in Q4 2023.
• A 3-year average of $6.8 million and a median of $6.2 million in 2025 frame the typical range for Invested Capital.